Artiva Biotherapeutics, Inc. ARTV Change in fair value of interest rate swap
Change in fair value of interest rate swap at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnDerivatives.
The official record: Artiva Biotherapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s change in fair value of interest rate swap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s change in fair value of interest rate swap?
- Artiva Biotherapeutics, Inc. (ARTV) reported change in fair value of interest rate swap of $0 in Q4 2025.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s change in fair value of interest rate swap?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s change in fair value of interest rate swap has grown at a -100.0% compound annual growth rate (CAGR), from -$707K to $0.
- What does change in fair value of interest rate swap mean?
- This metric captures the periodic change in the fair market value of derivative financial instruments, such as interest rate swaps, that have not yet been settled. It reflects the impact of market fluctuations on the company's hedging activities or speculative financial positions. Monitoring this helps investors understand the volatility introduced by financial risk management strategies on the bottom line.